ALKS vs TFX · P/E 14, rev $1.56B vs P/E 2083, rev $3.05B
Alkermes Plc (ALKS) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported TFX revenue for 2024-12-31 was $3.05B. Net income was $69.7M. Revenue was up 2.4% from 2023-12-31 to 2024-12-31. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the ALKS and TFX stock pages for the full models.
Not investment advice.